Statement of Changes in Beneficial Ownership (4)
2018年3月2日 - 3:19AM
Edgar (US Regulatory)
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Farley Brian E
|
2. Issuer Name
and
Ticker or Trading Symbol
ENTELLUS MEDICAL INC
[
ENTL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
3600 HOLLY LANE NORTH, SUITE 40
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/28/2018
|
(Street)
PLYMOUTH, MN 55447
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.001 par value
|
2/28/2018
|
|
D
|
|
291743
|
D
|
$24
(1)
|
0
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (right to buy)
|
$1.36
|
2/28/2018
|
|
D
|
|
|
39563
|
(2)
|
3/24/2020
|
Common Stock
|
39563
|
$22.64
|
0
|
D
|
|
Stock Option (right to buy)
|
$0.76
|
2/28/2018
|
|
D
|
|
|
28439
|
(3)
|
2/8/2022
|
Common Stock
|
28439
|
$23.24
|
0
|
D
|
|
Stock Option (right to buy)
|
$1.24
|
2/28/2018
|
|
D
|
|
|
34510
|
(4)
|
3/19/2023
|
Common Stock
|
34510
|
$22.76
|
0
|
D
|
|
Stock Option (right to buy)
|
$11.36
|
2/28/2018
|
|
D
|
|
|
188800
|
(5)
|
12/16/2024
|
Common Stock
|
188800
|
$12.64
|
0
|
D
|
|
Stock Option (right to buy)
|
$18.26
|
2/28/2018
|
|
D
|
|
|
10000
|
(6)
|
6/14/2026
|
Common Stock
|
10000
|
$5.74
|
0
|
D
|
|
Stock Option (right to buy)
|
$13.38
|
2/28/2018
|
|
D
|
|
|
5000
|
(7)
|
6/13/2027
|
Common Stock
|
5000
|
$10.62
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
|
(2)
|
This option, which was fully vested on January 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
(3)
|
This option, which was fully vested on December 31, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
(4)
|
This option, which was fully vested on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
(5)
|
This option, which provided for vesting in 48 equal monthly installments commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
(6)
|
This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
(7)
|
This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Farley Brian E
3600 HOLLY LANE NORTH, SUITE 40
PLYMOUTH, MN 55447
|
X
|
|
|
|
Signatures
|
/s/ Brent A. Moen, attorney-in-fact
|
|
3/1/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
過去 株価チャート
から 8 2024 まで 9 2024
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Entellus Medical, Inc. (delisted) (ナスダック市場): 0 recent articles
その他のEntellus Medical Incニュース記事